CXCL9 and neoplasm: CXCL9 was also induced in the metronomic CPA-treated tumor cells in association with other extracellular immune activators: TNFSF4, MICB, interleukins IL12, IL15, IL23, and IL17RB, and interferon response genes (Figure 1C).